Advance Medical Research Center

Miami, Florida 33165

1 studies enrolling now · 20 studies all time

What they study most

Agitation Associated With Alzheimer's Dementia, Agitation in Participants With Dementia of the Alzheimer's Type, Alzheimer Disease, Alzheimer's Disease, Atopic Dermatitis, Chronic Anal Fissures, Crohn Disease, Cutaneous Lupus Erythematosus (CLE), Dermatomyositis, Diabetic Foot Ulcer, Heart Failure, Heart Failure With Preserved Ejection Fraction

Studies at this site

• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia — Recruiting now
• A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease — Recruiting now
• The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) — Running, not enrolling
• Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. — Running, not enrolling
• The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) — Completed
• A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis — Running, not enrolling
• Safety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment — Completed
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) — Completed
• A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES) — Completed
• Global Prevalence of ATTR-CM in Participants With HFpEF — Stopped early
• Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease — Running, not enrolling
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type — Completed
• This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms. — Completed
• This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms — Completed
• BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease — Withdrawn before enrolling
• Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers — Completed
• Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers — Completed
• Efficacy and Safety Study With Diltiazem Hydrochloride Cream to Treat Anal Fissures — Completed